Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21623279 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib
Condition: Lung Cancer
Intervention: Drug: dasatinib

Indicates status has not been verified in more than two years